MeVis Medical Solutions Balance Sheet Health
Financial Health criteria checks 6/6
MeVis Medical Solutions has a total shareholder equity of €17.8M and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €25.1M and €7.3M respectively. MeVis Medical Solutions's EBIT is €4.7M making its interest coverage ratio -37.1. It has cash and short-term investments of €4.9M.
Key information
0%
Debt to equity ratio
€0
Debt
| Interest coverage ratio | -37.1x |
| Cash | €4.87m |
| Equity | €17.83m |
| Total liabilities | €7.30m |
| Total assets | €25.13m |
Recent financial health updates
No updates
Recent updates
MeVis Medical Solutions (ETR:M3V) Is Very Good At Capital Allocation
Nov 30
Most Shareholders Will Probably Find That The CEO Compensation For MeVis Medical Solutions AG (ETR:M3V) Is Reasonable
Mar 16MeVis Medical Solutions (ETR:M3V) Has More To Do To Multiply In Value Going Forward
Feb 14Should You Use MeVis Medical Solutions' (ETR:M3V) Statutory Earnings To Analyse It?
Feb 22MeVis Medical Solutions AG's (ETR:M3V) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat?
Feb 01
Financial Position Analysis
Short Term Liabilities: M3V's short term assets (€8.2M) exceed its short term liabilities (€1.8M).
Long Term Liabilities: M3V's short term assets (€8.2M) exceed its long term liabilities (€5.5M).
Debt to Equity History and Analysis
Debt Level: M3V is debt free.
Reducing Debt: M3V has not had any debt for past 5 years.
Debt Coverage: M3V has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: M3V has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 11:31 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MeVis Medical Solutions AG is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Bissinger | Dz Bank Ag |
| FELIX ELLMANN | Warburg Research GmbH |
| Harald Hof | Warburg Research GmbH |